TREM2 upregulation had also been determined in peripheral mononuclear cells from AD patients and mild cognitive impairment [52,53], implicating that the TREM2 upregulation may be a systemic response of myeloid cells with the progression of AD. Here, TREM2 is linked to Cognitive impairment.